customer service software

Global Pancreatic Cancer Therapeutics Diagnostics Market

  • Published Date: 06 May 2018
  • Number of Pages: 173
  • Category: Healthcare and Medical
  • Country: Global
The uncontrolled growth of cells in the pancreas causes pancreatic cancer. It is an abnormal, unrestrained growth of cells which leads to formation of lumps in the tissues, usually referred to as tumors. These tumors prevent the normal functioning of the pancreas. According to SEER, around 7% of the total cancer deaths is accounted by pancreatic cancer. Its occurrence and mortality rate is comparatively high in men than in women. Smoking is the biggest risk factor leading to pancreatic cancer. The other risk factors include lifestyle dependent factors like obesity, alcohol consumption, etc. Also, old age and personal or family history of pancreatitis are the other factors that may lead to pancreatic cancer.
Globally, pancreatic cancer is the 11th most common cancer in women and 12th most common cancer in men.

Market Dynamics

The U.S. records the highest number of pancreatic cancer patients in the world. Thus, it forms the largest market for the pancreatic cancer therapeutics and diagnostics. Following are the different driving and restraining factors for the global pancreatic cancer therapeutics and diagnostics:

--> Growing concern across the world
--> Increasing healthcare expenditure
--> Technological developments & drug innovations with respect to the pancreatic cancer

--> Difficulty in diagnosis during the early stages
--> Limited treatment options
--> Inadequate results after treatment
--> Low success rates in clinical trials for cancer drugs
--> High cost associated with the treatment
--> Adverse side-effects

Market Segmentation

Segmentation based on type of cancer:
--> Endocrine cancer
--> Exocrine cancer

Segmentation based on type of treatment:
--> Surgery
--> Chemotherapy
--> Radiation therapy
--> Targeted therapy

Segmentation based on type of tests:
--> Biopsy
--> Endoscopic ultrasound
--> Laparoscopy
--> CT scan ERCP

Segmentation based on geography:
--> North America
--> Europe
--> Asia-Pacific
--> Latin America
--> Middle East & Africa


Owing to the increase in the technological advancements with respect to cancer treatment methods in tandem with high incidences of pancreatic cancer, North America dominates the pancreatic cancer diagnostics and therapeutics market. Europe holds the second position in this market. The emerging economies in Asia-Pacific regions such as India and China are also expected to show significant growth in this market during the forecast period.

Key Players

Amgen, Eli Lilly and Company, Celgene Corporation, Clovis Oncology, Novartis AG, Threshold Pharmaceuticals, Incyte Corp, Merrimack Pharmaceuticals, Roche Ltd, NewLink Genetics

Report Contents:

> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe

> Eastern Europe

>> Russia
>> Poland
>> Rest of Eastern Europe

> Asia Pacific

>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage

Publisher Name : Market Litmus

Abstract: The Southeast Asia Nebulizer inhaler market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by

View Report

Abstract: The Southeast Asia Oxygen bag market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by

View Report

Abstract: The Southeast Asia Oxygen Regulator market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports